ヒュージョン Company Profile

Non-invasive and non-contact healthcare solution using proprietary biological signal analysis technology.

Our company was established in May 2020, initially focusing on developing digital thermography systems, and we experienced growth in sales against the backdrop of the COVID-19 pandemic. As the COVID-related business began to stabilize, we upgraded the aforementioned digital thermography system and are now working on a non-invasive, non-contact healthcare solution using our unique cutting-edge biosignal analysis technology based on the Prime-rPPG method. Leveraging the know-how gained from our broadband distribution business, as well as our experience in building cloud services via the internet and developing and commercializing digital thermography systems, we are engaged in planning, development, manufacturing, and sales focused on vital signs, expanding this business in collaboration with partner companies both domestically and internationally. (*The rPPG method stands for "Remote Photoplethysmography," which is a cutting-edge technology that analyzes and estimates biological information by examining changes in vascular vibrations caused by blood flow through images.) As a product, it is a system that measures vital signs such as body temperature, pulse rate, oxygen saturation, and blood pressure in about 10 seconds as one of its terminal functions.